Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | JAB-3312 |
| Trade Name | |
| Synonyms | JAB3312|JAB 3312|sitneprotafib |
| Drug Descriptions |
JAB-3312 is a SHP2 inhibitor, which potentially decreases tumor growth (PMID: 40304209). |
| DrugClasses | SHP2 Inhibitor 20 |
| CAS Registry Number | NA |
| NCIT ID | C164218 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Binimetinib + JAB-3312 | Binimetinib JAB-3312 | 0 | 1 |
| Cobimetinib + JAB-3312 | Cobimetinib JAB-3312 | 0 | 0 |
| Glecirasib + JAB-3312 | Glecirasib JAB-3312 | 0 | 0 |
| JAB-3312 | JAB-3312 | 5 | 0 |
| JAB-3312 + Osimertinib | JAB-3312 Osimertinib | 0 | 1 |
| JAB-3312 + Pembrolizumab | JAB-3312 Pembrolizumab | 0 | 1 |
| JAB-3312 + Sotorasib | JAB-3312 Sotorasib | 0 | 1 |